In the wake of the increase in Current Liabilities in the fourth quarter 2024, Quick Ratio fell to 2.84 below Nevro Corp average.

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Quick Ratio than Nevro in fourth quarter 2024. While Quick Ratio total ranking has improved so far during the Q4 2024 to 535, from total ranking in the third quarter 2024 at 901.

Explain Quick Ratio?
How much Cash & cash equivalents NVRO�s has?
What are NVRO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVRO Quick Ratio	(Dec 31 2024) Q4	(Sep 30 2024) Q3	(Jun 30 2024) Q2	(Mar 31 2024) Q1	(Dec 31 2023) Q4
Y / Y Current Liabilities Change	23.47 %	165.64 %	75.77 %	-17.95 %	153.34 %
Y / Y Cash & cash equivalent Change	-9.35 %	-13.5 %	-17.05 %	-17.64 %	-13.8 %
Quick Ratio MRQ	2.84	2.9	4.2	9.61	3.87
NVRO's Total Ranking	# 535	# 901	# 885	# 484	# 679
Seq. Current Liabilities Change	7.89 %	46.31 %	122.63 %	-64.87 %	132.13 %
Seq. Cash & cash equivalent Change	5.59 %	1.22 %	-2.77 %	-12.78 %	0.77 %

Quick Ratio fourth quarter 2024 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 31
Healthcare Sector	# 240
Overall Market	# 535

Quick Ratio Statistics
High	Average	Low
16.37	5.42	2.34
(Dec 31 2014)		(Mar 31 2021)

Financial Statements
Nevro 's Current Liabilities	$ 103 Millions	Visit NVRO's Balance sheet
Nevro 's Cash & cash equivalent	$ 293 Millions	Visit NVRO's Balance sheet
Source of NVRO's Sales		Visit NVRO's Sales by Geography

Cumulative Nevro 's Quick Ratio

NVRO's Quick Ratio for the trailling 12 Months

NVRO Quick Ratio	(Dec 31 2024) 12 Months	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months
Y / Y Current Liabilities TTM Growth	52.46 %	92.97 %	49.12 %	29.71 %	37.3 %
Y / Y Cash & cash equivalent TTM Growth	-14.45 %	-15.47 %	-16.39 %	-11.28 %	-5.81 %
Quick Ratio TTM	3.84	4.23	5.6	6.76	6.84
Total Ranking TTM	# 3520	# 3196	# 683	# 2250	# 3450
Seq. Current Liabilities TTM Growth	7.16 %	27.83 %	15.14 %	-3.34 %	35.63 %
Seq. Cash & cash equivalent TTM Growth	-2.61 %	-3.61 %	-4.48 %	-4.59 %	-3.78 %

Quick ratio ranking by company, industry and sector >> Back to NVRO Financial Strength Comparisons >> Go to Compare NVRO Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2024 to $102.94 millions, cumulative Quick Ratio decreased to 3.84 below the Nevro Corp average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 202 other companies have achieved higher Quick Ratio than Nevro . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2024 from 3196 to 3520.

Explain Quick Ratio?
How much Cash & cash equivalents NVRO�s has?
What are NVRO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 203
Healthcare Sector	# 920
Within the Market	# 3520

trailing twelve months Quick Ratio Statistics
High	Average	Low
7.91	4.57	2.43
(Mar 31 2017)		(Mar 31 2021)

Companies with similar Quick Ratio in the quarter ending Dec 31 2024, within Medical Equipment & Supplies Industry	Quick Ratio	Dec 31 2024 MRQ Cash & cash equivalent	Dec 31 2024 MRQ Current Liabilities
Sight Sciences Inc	7.78	$ 120.357 Millions	$ 15.468 Millions
Orasure Technologies Inc	7.62	$ 267.763 Millions	$ 35.155 Millions
Valion Bio Inc	7.36	$ 2.002 Millions	$ 0.272 Millions
Carlsmed Inc	7.30	$ 40.125 Millions	$ 5.499 Millions
Penumbra Inc	7.09	$ 340.131 Millions	$ 47.949 Millions
Talkspace Inc	7.07	$ 117.810 Millions	$ 16.653 Millions
Nexalin Technology Inc	6.37	$ 3.480 Millions	$ 0.547 Millions
Tactile Systems Technology Inc	6.29	$ 94.367 Millions	$ 15.014 Millions
Iradimed Corporation	6.14	$ 52.234 Millions	$ 8.512 Millions
Alpha Pro Tech Ltd	5.97	$ 18.636 Millions	$ 3.123 Millions
Anteris Technologies Global Corp	5.96	$ 70.458 Millions	$ 11.822 Millions
Irhythm Holdings Inc	5.81	$ 535.553 Millions	$ 92.121 Millions
Transmedics Group Inc	5.62	$ 336.650 Millions	$ 59.913 Millions
Bluejay Diagnostics Inc	5.31	$ 4.302 Millions	$ 0.810 Millions
Procept Biorobotics Corporation	5.30	$ 333.725 Millions	$ 62.966 Millions
Inspiremd Inc	4.51	$ 34.637 Millions	$ 7.678 Millions
Glucotrack Inc	4.41	$ 5.617 Millions	$ 1.275 Millions
Nutriband Inc	4.39	$ 4.312 Millions	$ 0.983 Millions
Hyperfine Inc	4.31	$ 37.645 Millions	$ 8.729 Millions
Orchestra Biomed Holdings Inc	4.27	$ 66.812 Millions	$ 15.657 Millions
Glaukos Corp	4.25	$ 318.915 Millions	$ 75.125 Millions
Nakamoto Inc	3.78	$ 2.293 Millions	$ 0.606 Millions
Sensus Healthcare Inc	3.75	$ 22.056 Millions	$ 5.885 Millions
Innovative Eyewear Inc	3.56	$ 2.629 Millions	$ 0.738 Millions
Avita Medical Inc	3.51	$ 70.735 Millions	$ 20.158 Millions
Medinotec Inc	3.50	$ 2.809 Millions	$ 0.803 Millions
Outset Medical Inc	3.50	$ 158.685 Millions	$ 45.378 Millions
Tenon Medical Inc	3.50	$ 6.535 Millions	$ 1.869 Millions
Neuropace Inc	3.48	$ 52.755 Millions	$ 15.156 Millions
Co diagnostics Inc	3.44	$ 29.748 Millions	$ 8.644 Millions

Date modified: 2026-09-08T15:11:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.